Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.64
CASM's Cash to Debt is ranked higher than
62% of the 287 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.15 vs. CASM: 0.64 )
CASM' s 10-Year Cash to Debt Range
Min: 0.07   Max: No Debt
Current: 0.64

Equity to Asset 0.30
CASM's Equity to Asset is ranked higher than
50% of the 275 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 0.60 vs. CASM: 0.30 )
CASM' s 10-Year Equity to Asset Range
Min: 0.3   Max: 0.86
Current: 0.3

0.3
0.86
F-Score: 3
Z-Score: -0.29
M-Score: -3.13
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Operating margin (%) -36.28
CASM's Operating margin (%) is ranked higher than
51% of the 286 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 9.64 vs. CASM: -36.28 )
CASM' s 10-Year Operating margin (%) Range
Min: -47.7   Max: 20.86
Current: -36.28

-47.7
20.86
Net-margin (%) -39.04
CASM's Net-margin (%) is ranked higher than
52% of the 286 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.97 vs. CASM: -39.04 )
CASM' s 10-Year Net-margin (%) Range
Min: -47.28   Max: 13.21
Current: -39.04

-47.28
13.21
ROE (%) -110.84
CASM's ROE (%) is ranked lower than
52% of the 276 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 8.15 vs. CASM: -110.84 )
CASM' s 10-Year ROE (%) Range
Min: -93.04   Max: 35.61
Current: -110.84

-93.04
35.61
ROA (%) -50.21
CASM's ROA (%) is ranked lower than
51% of the 288 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.87 vs. CASM: -50.21 )
CASM' s 10-Year ROA (%) Range
Min: -53.75   Max: 26.71
Current: -50.21

-53.75
26.71
ROC (Joel Greenblatt) (%) -129.78
CASM's ROC (Joel Greenblatt) (%) is ranked higher than
52% of the 287 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 20.54 vs. CASM: -129.78 )
CASM' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -184.6   Max: 241.38
Current: -129.78

-184.6
241.38
Revenue Growth (%) -11.10
CASM's Revenue Growth (%) is ranked higher than
56% of the 261 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.50 vs. CASM: -11.10 )
CASM' s 10-Year Revenue Growth (%) Range
Min: -22.5   Max: 25.4
Current: -11.1

-22.5
25.4
EBITDA Growth (%) 109.30
CASM's EBITDA Growth (%) is ranked higher than
99% of the 219 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.30 vs. CASM: 109.30 )
CASM' s 10-Year EBITDA Growth (%) Range
Min: 0   Max: 109.3
Current: 109.3

0
109.3
EPS Growth (%) 77.70
CASM's EPS Growth (%) is ranked higher than
98% of the 218 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 5.90 vs. CASM: 77.70 )
CASM' s 10-Year EPS Growth (%) Range
Min: -37   Max: 136.6
Current: 77.7

-37
136.6
» CASM's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2013

CASM Guru Trades in Q2 2013

Jim Simons 12,200 sh (-10.29%)
» More
Q3 2013

CASM Guru Trades in Q3 2013

Jim Simons Sold Out
» More
Q2 2014

CASM Guru Trades in Q2 2014

Jim Simons 12,400 sh (New)
» More
Q3 2014

CASM Guru Trades in Q3 2014

Jim Simons 15,200 sh (+22.58%)
» More
» Details

Insider Trades

Latest Guru Trades with CASM

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Guru Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/S 1.50
CASM's P/S is ranked higher than
84% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.92 vs. CASM: 1.50 )
CASM' s 10-Year P/S Range
Min: 0.38   Max: 6.14
Current: 1.5

0.38
6.14
EV-to-EBIT -6.31
CASM's EV-to-EBIT is ranked lower than
54% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 29.27 vs. CASM: -6.31 )
CASM' s 10-Year EV-to-EBIT Range
Min: -803.9   Max: 133.9
Current: -6.31

-803.9
133.9
Current Ratio 3.27
CASM's Current Ratio is ranked higher than
79% of the 275 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 2.72 vs. CASM: 3.27 )
CASM' s 10-Year Current Ratio Range
Min: 2.12   Max: 9.01
Current: 3.27

2.12
9.01
Quick Ratio 2.14
CASM's Quick Ratio is ranked higher than
75% of the 275 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.85 vs. CASM: 2.14 )
CASM' s 10-Year Quick Ratio Range
Min: 0.87   Max: 7.36
Current: 2.14

0.87
7.36

Valuation & Return

vs
industry
vs
history
Price/Median PS Value 1.20
CASM's Price/Median PS Value is ranked higher than
69% of the 300 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 1.20 vs. CASM: 1.20 )
CASM' s 10-Year Price/Median PS Value Range
Min: 0.17   Max: 2.99
Current: 1.2

0.17
2.99
Earnings Yield (Greenblatt) -16.00
CASM's Earnings Yield (Greenblatt) is ranked higher than
51% of the 284 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 4.00 vs. CASM: -16.00 )
CASM' s 10-Year Earnings Yield (Greenblatt) Range
Min: -16   Max: 10.7
Current: -16

-16
10.7
Forward Rate of Return (Yacktman) 19.45
CASM's Forward Rate of Return (Yacktman) is ranked higher than
94% of the 247 Companies
in the Global Medical Instruments & Supplies industry.

( Industry Median: 3.17 vs. CASM: 19.45 )
CASM' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -30   Max: 39.7
Current: 19.45

-30
39.7

Business Description

Industry: Medical Instruments & Equipment » Medical Instruments & Supplies
Compare: » details
Traded in other countries:UM1.Germany
CAS Medical Systems Inc is a Delaware corporation organized in 1984. It is a medical technology company that develops, manufactures and markets non-invasive patient monitoring products that are vital to patient care. Its products include the FORE-SIGHT Absolute Tissue Oximeter and sensors, and its Traditional Monitoring products which include MAXNIBP blood pressure measurement technology, bedside monitoring products, and neonatal vital signs supplies. These products are designed to provide accurate, non-invasive, biologic measurements that guide clinicians to provide better patient care. The Company reports two categories of revenue within one reportable business unit: Tissue Oximetry Monitoring includes sales of the Companys FORE-SIGHT Absolute Tissue Oximeter monitors, sensors and accessories; and Traditional Monitoring includes sales of the Companys traditional vital signs products and services including sales to Original Equipment Manufacturers (OEM) of the Companys proprietary non-invasive blood pressure technology (MAXNIBP) for inclusion in the OEM customers own multi-parameter monitors; bedside vital signs monitors and accessories incorporating various combinations of measurement parameters for both human and veterinary use such as MAXNIBP non-invasive blood pressure, pulse oximetry, electrocardiography (ECG), temperature, and capnography (CO² measurements); neonatal intensive care vital signs supplies including electrodes and skin temperature probes and service repair. The Company markets its products through hospital, surgery center and outpatient facility, homecare, veterinary and emergency medical distribution channels. The Company competes in the broader medical equipment market for patient monitoring equipment and supplies. Medical products of the type currently being marketed and under development by the Company are subject to regulation under the Food, Drug and Cosmetic Act (the FD&C Act) and numerous acts and amendments such as the Quality System Regulations (QSR), often referred to as Good Manufacturing Practices (GMP's). The Company also offers a line of non-invasive vital signs monitoring products for various general care settings, such as hospital wards, outpatient medical surgical units, recovery rooms, procedure labs, physician offices, long term care facilities, and emergency response settings.
» More Articles for CASM

Headlines

Articles On GuruFocus.com
CAS Medical Systems Inc. (CASM) CEO Thomas M Patton buys 20,000 Shares Dec 08 2010 
CAS Medical Systems Inc. Reports Operating Results (10-Q) Nov 10 2010 
CAS Medical Systems Inc. Reports Operating Results (10-Q) Aug 04 2010 
CAS Medical Systems Inc. Reports Operating Results (10-Q) May 05 2010 
CAS Medical Systems Inc. Reports Operating Results (10-Q) Nov 05 2009 
CAS Medical Systems Inc. Reports Operating Results (10-Q) Aug 12 2009 
CAS Medical Systems Inc. Reports Operating Results (10-Q) May 06 2009 

More From Other Websites
Nasdaq stocks posting largest volume increases Nov 21 2014
November 18 CASMED to Present at the LD MICRO MAIN EVENT: VII Conference on December 2, 2014 Nov 18 2014
CASMED to Present at the LD MICRO MAIN EVENT: VII Conference on December 2, 2014 Nov 18 2014
CAS MEDICAL SYSTEMS INC Financials Nov 14 2014
10-Q for CAS Medical Systems, Inc. Nov 06 2014
November 04 CASMED Announces Third Quarter 2014 Financial Results FORE-SIGHT® Sales Increase 55%,... Nov 04 2014
Q3 2014 CAS Medical Systems Inc Earnings Release - Before Market Open Nov 04 2014
CAS MEDICAL SYSTEMS INC Files SEC form 8-K, Results of Operations and Financial Condition Nov 04 2014
CASMED Announces Third Quarter 2014 Financial Results Nov 04 2014
October 28 CASMED to Announce Third Quarter 2014 Financial Results and Hold Conference Call on... Oct 28 2014
CASMED to Announce Third Quarter 2014 Financial Results and Hold Conference Call on November 4th Oct 28 2014
CAS MEDICAL SYSTEMS INC Files SEC form 8-K, Change in Directors or Principal Officers Oct 09 2014
CASMED to Participate in BTIG's Inaugural Emerging Technologies in Healthcare Diagnostics Symposium Sep 25 2014
CASMED to Present at the 5th Annual Craig-Hallum Alpha Select Conference Sep 05 2014
CAS MEDICAL SYSTEMS INC Files SEC form 8-K, Results of Operations and Financial Condition Aug 06 2014
CAS MEDICAL SYSTEMS INC Files SEC form 8-K, Other Events Jul 02 2014
CAS MEDICAL SYSTEMS INC Files SEC form 8-K, Creation of a Direct Financial Obligation or an... Jun 30 2014
CAS MEDICAL SYSTEMS INC Files SEC form 8-K, Change in Directors or Principal Officers, Submission of... Jun 27 2014
CAS Medical cleared to market Fore-Sight Elite Oximeters in Japan Jun 26 2014
CAS Medical receives FDA approval for Fore-Sight Elite in non-cerebral tissue May 07 2014
CAS MEDICAL SYSTEMS INC Files SEC form 10-Q, Quarterly Report May 02 2014
CAS MEDICAL SYSTEMS INC Files SEC form 8-K, Results of Operations and Financial Condition May 01 2014
March 20 CASMED Places 1,000th FORE-SIGHT® Cerebral Oximeter Mar 20 2014
CAS MEDICAL SYSTEMS INC Files SEC form 10-K, Annual Report Mar 19 2014
March 18 CASMED Names Karen Harris-Coleman Executive Vice President, International Sales Mar 18 2014
CAS MEDICAL SYSTEMS INC Files SEC form 8-K, Notice of Delisting or Failure to Satisfy a Continued... Mar 17 2014
CAS Medical Systems' CEO Discusses Q4 2013 Results - Earnings Call Transcript Mar 07 2014
CAS MEDICAL SYSTEMS INC Files SEC form 8-K, Results of Operations and Financial Condition Mar 06 2014
December 3 CASMED Places 900th FORE-SIGHT Cerebral Oximeter Dec 03 2013
November 25 CASMED Receives China Food and Drug Administration Approvalfor FORE-SIGHT Cerebral... Nov 25 2013

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK